**Arthur Hayes: From Crypto Pioneer to Longevity Investor**
Arthur Hayes achieved remarkable success, facing legal challenges and a presidential pardon before turning 40. He transformed BitMEX into a leading cryptocurrency trading platform, only to witness it struggle under regulatory scrutiny. After receiving a pardon from President Donald Trump, which cleared his conviction alongside his co-founders, Hayes is now focusing on new investments, particularly in the field of longevity.
Recently, Hayes acquired a significant stake in a stem cell company operating clinics in Mexico and Bangkok, where he has been a regular patient for over a year. His treatments aim to enhance his healthspan, reflecting his commitment to living a long and healthy life. In a video interview, Hayes expressed, “I want to live as long as possible, as healthy as possible,” highlighting the growing acceptance of stem cell therapies worldwide.
Although Hayes did not disclose the name of the company due to an ongoing rebranding, he confirmed his position on the board since this summer. In March, Trump pardoned Hayes, Benjamin Delo, and Samuel Reed, the co-founders of BitMEX, who faced charges for violating the Bank Secrecy Act. They pleaded guilty in 2022, agreeing to forfeit $10 million each and receiving probation. Despite the pardon, Hayes noted that his professional life remained largely unchanged, as he had already relocated to Singapore and spent part of each year skiing in Japan.
Hayes continues to be an influential voice in the crypto community, with his essays on topics ranging from meme culture to monetary theory garnering significant attention. One of his posts, “Dust on Crust,” inspired the creation of Ethena’s synthetic dollar, which has become a major player in the stablecoin market.
As the cryptocurrency market experiences a resurgence, Hayes and other crypto innovators are redirecting their efforts toward industries they perceive as outdated or overly regulated. This includes ventures in stem cells, speculative tokens, AI-driven education, and publicly traded companies accumulating crypto assets. The trend reflects a broader ambition among industry leaders to explore new frontiers, with longevity emerging as a key focus.
Notable figures in the crypto space are also investing in longevity. Ethereum co-founder Vitalik Buterin has contributed millions to life-extension research, while former Coinbase CTO Balaji Srinivasan supports biotech initiatives. Coinbase CEO Brian Armstrong co-founded NewLimit, a genetic engineering startup that recently raised $130 million in funding.
As the landscape of digital assets evolves, companies that accumulate cryptocurrency on their balance sheets are gaining traction, signaling a shift in how traditional finance intersects with the burgeoning crypto market.
**FAQ**
**What is Arthur Hayes currently investing in?**
Arthur Hayes is investing in a stem cell business focused on longevity, alongside other ventures in the cryptocurrency and biotech sectors.